CTI BioPharma Announces Oral Presentation at the 62nd American Society of Hematology Meeting ...Middle East

SEATTLE, Nov. 4, 2020 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today announced an oral presentation supporting the Company's pacritinib development program in graft versus host disease (GVHD) at the 62nd American Society of Hematology (ASH) Annual Meeting & Exposition, being...

Read More Details
Finally We wish PressBee provided you with enough information of ( CTI BioPharma Announces Oral Presentation at the 62nd American Society of Hematology Meeting )

Also on site :

• Japan starts deploying Osprey fleet at a new base to beef up southwestern defense
• South Africa seeks US trade deal after Trump’s 30% citrus tariff
• Josh O’Connor Goes Full Cowboy in ‘Rebuilding’ as Director Max Walker-Silverman Takes on Life After the Fires: ‘Loss Often Comes With Love’